Search Results

SirPAD Evaluates Concept Medical’s MagicTouch Sirolimus-Coated Balloon

April 1, 2026—Concept Medical Inc. announced the presentation of primary results of the SirPAD randomized controlled trial of the company’s MagicTouch sirolimus-coated balloon for percutaneous transluminal angioplasty (PTA) to treat peripheral artery disease (PAD).

ULTIMA Will Study Treatment of Pulmonary Embolism Using the Ekos EkoSonic Endovascular Device

January 18, 2010—Ekos Corporation (Bothell, WA) announced that the company is in the final planning and approval stages for the ULTIMA (Ultrasound Accelerated Thrombolysis of Pulmonary Embolism) randomized clinical study.

Enrollment Begins in SirPAD Trial of Concept Medical’s MagicTouch PTA Catheter

November 9, 2020—Concept Medical Inc. announced the enrollment of the first patient in the SirPAD trial, an all-comers randomized controlled clinical trial (RCT) investigating major adverse limb events in peripheral artery disease (PAD) patients with lesions below the inguinal ligament.

Results of ULTIMA Trial Support Use of Ultrasound Accelerated Thrombolysis for Submassive PE

March 9, 2013—Results of the ULTIMA (Ultrasound Accelerated Thrombolysis of Pulmonary Embolism) trial, the first randomized, controlled trial comparing use of an endovascular approach with anticoagulation to treat submassive pulmonary embolism (PE) versus anticoagulation alone, were presented at the 62nd annual scientific session of the American College of Cardiology in San Francisco, California.

EkoSonic Device Receives CE Mark Approval to Treat Pulmonary Embolism

January 17, 2011—Ekos Corporation (Bothell, WA) announced that the company's EkoSonic endovascular system received CE Mark approval for the treatment of pulmonary embolism (PE) in Europe.

Concept Medical’s SirPAD Trial of MagicTouch PTA Device Completes Enrollment

January 20, 2025—Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percutaneous transluminal angioplasty (PTA) sirolimus-coated balloon in the treatment of peripheral artery disease (PAD).

Initial Commercialization Phase Begins for Plus Medica's Blueflow Venous Stent in Europe

April 3, 2018—Plus Medica, a Germany-based medical device company, announced that the first 10 patients have been treated with the company’s Blueflow venous stent, which is primarily used as an extension stent in patients with postthrombotic syndrome (PTS) and lesions that extend below the inguinal ligament.

Ekos' Devices to Be Studied

January 18, 2010—Ekos Corporation (Bothell, WA) acknowledged the beginning of the physician-sponsored DUET study.

SEATTLE II Enrollment Completed to Study Ekos' Ultrasound-Accelerated Thrombolyis Device to Treat Pulmonary Embolism

March 20, 2013—Ekos Corporation (Bothell, WA) announced the completion of the SEATTLE II clinical trial, a 150-patient, single-arm, prospective study measuring the rapid reduction in right heart strain in a patient population with both massive and submassive pulmonary embolism (PE) when treated with the EkoSonic ultrasound accelerated infusion catheter.